Adherence to isoniazid prophylaxis in the homeless: A randomized controlled trial

Archives of Internal Medicine

Volumn 160, Issue 5, 2000, Pages 697-702

  Tulsky, Jacqueline Peterson ^a,e   Pilote, Louise ^b   Hahn, Judith A ^a   Zolopa, Andrew J ^c   Burke, Michele ^e   Chesney, Margaret ^d   Moss, Andrew R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CAREGIVER; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOMELESSNESS; HOUSING; HUMAN; MAJOR CLINICAL STUDY; MALE; MONEY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PEER REVIEW; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0034642839     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zolopa A, Hahn J, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA. 1994;272:455-461.
2. Barnes P, El-Hajj H, Preston-Martin S, et al. Transmission of tuberculosis among the urban homeless. JAMA. 1997;275:305-307.
3. Tuberculosis among residents of shelters for the homeless - Ohio, 1990. MMWR Morb Mortal Wkly Rep. 1991;40:869-871, 877.
4. Nardell E, McInnis B, Thomas B, Weidhaus S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570-1575.
5. Prevention and control of tuberculosis among homeless persons: recommen-dation of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41(RR-5):13-23.
6. The use of preventive therapy for tuberculosis infection in the United States: recommendations from the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1990;39:9-12.
7. Pilote L, Tulsky JP, Zolopa A, Hahn J, Schecter G, Moss A. Tuberculosis prophylaxis in the homeless: a trial to improve adherence to referral. Arch Intern Med. 1996;156:161-165.
8. Nazar-Stewart V, Nolan CM. Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men. Am Rev Respir Dis. 1992;146:57-60.
9. Tuberculosis in San Francisco, 1996. Annual Report of the City and County of San Francisco. San Francisco, Calif: TB Control Division; 1996:1-5.
10. Weis S, Slocum P, Blais F, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1184.
11. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City: turning the tide. N Engl J Med. 1995;333:229-233.
12. Committee on Isoniazid Preventive Treatment, American College of Chest Physicians. Preventive treatment of tuberculosis. Chest. 1985;87(suppl):128S-132S.
13. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-1907.
14. Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis. 1990;142:848-853.
15. Brown R, Miller B, Taylor W, et al. Health-care expenditures for tuberculosis in the United States. Arch Intern Med. 1995;155:1595-1600.
16. Brudney K, Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Semin Respir Infect. 1991;6:261-272.
17. Sumartojo E. When tuberculosis treatment fails: a social behavior account of patient adherence. Am Rev Resp Dis. 1993;147:1311-1320.
18. Slutkin G. Management of tuberculosis in urban homeless indigents. Public Health Rep. 1986;101:481-485.
19. Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Public Health Rep. 1992;107:626-636.
20. Silverman K, Higgins S, Brooner R, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53:409-415.
21. Stevens-Simon C, Dolgan JI, Kelly L, Singer D. The effect of monetary incentives and peer support groups on repeat adolescent pregnancies. JAMA. 1996; 277;977-982.
22. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998; 88:792-796.
23. FitzGerald JM, Patrick DM, Strathdee S, et al. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Int J Tuberc Lung Dis. 1999;3:153-155.
24. Giuffrida A, Torgerson DJ. Should we pay the patient? review of financial incentives to enhance patient compliance. BMJ. 1997;315:703-707.
25. Hill J, Ramachandran G. A simple scheme to improve compliance in patients taking tuberculosis medication. Trop Doct. 1992;22:161-163.
26. Incentives in TB prevention. CDC FB Monitor. March 1997.
27. Oscherwitz T, Tulsky JP, Roger S, et al. Detention of persistently nonadherent tuberculosis patients. JAMA. 1997;278:843-846.
28. Giblin P. Effective utilization and evaluation of indigenous health care workers. Public Health Rep. 1989;4:361-368.
29. Hildebrand G. Guidelines for effective use of nonprofessionals. Public Health Rep. 1970;85:773-786.
30. DíOnofrio C. Public health aides: pain or panacea? Public Health Rep. 1970;85: 788-801.